Acura Pharmaceuticals Inc (ACUR)
Acura Pharmaceuticals, Inc. is a healthcare company listed on OTC Markets as common stock under the symbol ACUR. The company focuses on research, development, and commercialization of drug-delivery technologies and products intended to support safer medication use in the United States. Its commercial products include Oxaydo tablets, a Schedule II narcotic approved for the management of acute and chronic moderate to severe pain, and Nexafed products, which combine pseudoephedrine and acetaminophen for use in nasal decongestant products sold in non-prescription and prescription cold, sinus, and allergy applications. Acura has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. for the worldwide manufacture and commercialization of Oxaydo products, as well as a development and commercialization agreement with Abuse Deterrent Pharma, LLC for LTX-03, an immediate-release tablet using LIMITx technology. Incorporated in 1935 and formerly known as Halsey Drug Co., Inc., the company is based in Palatine, Illinois.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-ACUR
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
6.664 K
|
